51 results
8-K
EX-10.1
IVRN
Innoveren Scientific, Inc.
30 Sep 20
Entry into a Material Definitive Agreement
12:00am
within the first thirty (30) days of the Employment Period.
3. Compensation and Benefits.
(a) Signing Bonus. Executive shall receive a one-time … signing bonus in the total gross amount of $30,000 payable upon the first available payroll date following the Effective Date.
(b) Base Salary. During
8-K
IVRN
Innoveren Scientific, Inc.
30 Sep 20
Entry into a Material Definitive Agreement
12:00am
will receive an annual salary of $400,000 per year. In addition, Mr. Greif shall be entitled to a $30,000 signing bonus upon execution and and shall … be entitled to a bonus of $50,000 at the end of year one. If the Employment Agreement continues for additional years, he will be entitled to an annual bonus
8-K
EX-10.1
IVRN
Innoveren Scientific, Inc.
27 Dec 21
Departure of Directors or Certain Officers
4:30pm
the Employment Period.
(b) Bonus. In addition to the Base Salary, Executive will have earned and be paid a one-time cash bonus in a gross amount equal … to $100,000.00 (a “Bonus”) if either of the following triggering events occur during the Employment Period:
(i) the Company’s common stock is listed
8-K
IVRN
Innoveren Scientific, Inc.
17 Jun 19
Departure of Directors or Certain Officers
9:14am
salary of $200,000. Gary Mancini was appointed Chief Relationship Officer at a base salary of $150,000 plus potential bonus, such bonus being subject to Mr
8-K
IVRN
Innoveren Scientific, Inc.
18 Oct 18
Entry into a Material Definitive Agreement
4:38pm
being issued.
2017 Executive bonus program. Executives were issued the following share amounts in lieu of cash due for 2017 bonus awards:
Jarrett Gorlin
8-K
EX-10.5
gkyax opu5tgy3p6v5
15 Oct 18
Medovex Corporation Names William E. Horne Chief Executive Officer and Chairman of the Board
5:28pm
PRE 14C
9gmqb1n brgf
5 Jun 19
Preliminary information
4:49pm
S-1/A
EX-14
p4mb0ibx0hbzn6ea7
7 Oct 14
IPO registration (amended)
12:00am
DEF 14C
n9m2c2w4v zts21y
25 Jan 19
Information statement
4:30pm
DEF 14C
t7a420gu6bajga8y
20 Jun 19
Information statement
12:00am
PRE 14C
r0e2d4a86q9gy83u y0c
11 Jan 19
Preliminary information
5:15pm
8-K
h262m 0cptq26u8vpa7
27 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
a4u79c54 52y4sqrs
15 Oct 18
Medovex Corporation Names William E. Horne Chief Executive Officer and Chairman of the Board
5:28pm
S-1/A
EX-99.3
a6kge u2tvef22
7 Oct 14
IPO registration (amended)
12:00am
8-K
EX-10.1
cmdyo7dof0
14 Jan 19
Medovex Corporation Closes Acquisition of Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
5:28pm
8-K
ijih8t3lg
30 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
di3y6sg
30 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
hosk8wyhv6x91a2
18 Oct 18
Entry into a Material Definitive Agreement
4:38pm